Page last updated: 2024-09-04

atrasentan and Heart Diseases

atrasentan has been researched along with Heart Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Abdelhady, SA; Darwish, IE; El-Deeb, NM; El-Mas, MM; Gowayed, MA; Habib, YH1
Kang, JJ; Kang, PM; Ke, Q; Kim, UK; Samad, MA1

Other Studies

2 other study(ies) available for atrasentan and Heart Diseases

ArticleYear
Prenatal endothelin or thromboxane receptor antagonism surpasses sympathoinhibition in improving cardiorenal malfunctions in preeclamptic rats.
    Toxicology and applied pharmacology, 2021, 09-01, Volume: 426

    Topics: Animals; Atrasentan; Endothelin A Receptor Antagonists; Female; Gene Expression Regulation; Heart Diseases; Hemodynamics; Kidney; Kidney Diseases; Myocardium; Naphthalenes; Pre-Eclampsia; Pregnancy; Propionates; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptors, Thromboxane A2, Prostaglandin H2

2021
Endothelin A receptor antagonist, atrasentan, attenuates renal and cardiac dysfunction in Dahl salt-hypertensive rats in a blood pressure independent manner.
    PloS one, 2015, Volume: 10, Issue:3

    Topics: Animals; Atrasentan; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Disease Models, Animal; Echocardiography; Endothelin A Receptor Antagonists; Gene Expression; Heart Diseases; Hemodynamics; Hypertension; Hypertrophy; Kidney Function Tests; Male; Myocytes, Cardiac; Phenylephrine; Pyrrolidines; Rats; Receptor, Endothelin A; Renal Insufficiency, Chronic

2015